Drug intelligence / Profile preview

clostridium butyricum live drops

Development stage: Unknown
Lead developer: Grand Life Sciences
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Clostridium butyricum live drops (capsule type) is a live biotherapeutic product containing the probiotic bacterium *Clostridium butyricum*. Developed by Hangzhou Grand Biopharma, the formulation is designed to restore gut microbiota balance and is being evaluated in clinical trials for the treatment of pediatric acute diarrhea. *Clostridium butyricum* is an anaerobic, spore-forming bacterium that produces butyric acid, a short-chain fatty acid (SCFA) that serves as a primary energy source for colonocytes, promotes intestinal mucosal barrier integrity, and exerts anti-inflammatory effects in the gastrointestinal tract.

Other names: 酪酸梭菌活菌滴剂酪酸梭菌活菌滴剂（胶囊型）

Beyond the preview

Go deeper on clostridium butyricum live drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on clostridium butyricum live drops.

Explore the full profile